The odds for participants who reported back pain to be seropositive for anti-CHIKV IgM antibodies were about two times larger compared to those without back pain (AOR = 1.785; 95% CI: 1.078–2.954), while the odds of participants with a rash to test positive for anti-CHIKV IgM antibodies were about 10 times larger compared to those without these symptoms, although the statistical significance of this finding was marginally insignificant (AOR = 10.124; 95% CI: 0.954–107.405) ( Table 3 ).
← all excerpts
High seroprevalence of IgM antibodies against chikungunya among patients with acute febrile illness seeking healthcare in a malaria-endemic area in the Afar Region, Northeast Ethiopia.
1
—
—